We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
(-17%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$364M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$155M |
| 3 |
Textron
TXT
|
+$103M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$102M |
| 5 |
Sanofi
SNY
|
+$96.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$333M |
| 2 |
ExxonMobil
XOM
|
+$242M |
| 3 |
Dollar Tree
DLTR
|
+$231M |
| 4 |
Nutrien
NTR
|
+$213M |
| 5 |
National Vision
EYE
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.53% |
| 2 | Healthcare | 17.73% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
GlobalFoundries
GFS
$28.5B
| $12.7M | 0.03% |
313,704
+84,544
| +37% | +$4.47M |
|
602
Safety Insurance
SAFT
$1.52B
| $12.6M | 0.03% |
130,000
+41,529
| +47% | +$3.74M |
|
|
AZEK
603
DELISTED
The AZEK Co
AZEK
| $12.6M | 0.03% |
750,000
+50,000
| +7% | +$1.03M |
|
604
Cboe Global Markets
CBOE
$30.1B
| $12.5M | 0.03% |
110,600
-800
| -0.7% | -$89.8K |
|
605
Conagra Brands
CAG
$7.18B
| $12.5M | 0.03% |
365,245
-135,700
| -27% | -$4.62M |
|
606
NiSource
NI
$21.3B
| $12.5M | 0.03% |
422,662
+12,600
| +3% | +$382K |
|
|
CMA
607
DELISTED
Comerica
CMA
| $12.4M | 0.03% |
169,472
+38,000
| +29% | +$3.07M |
|
|
BRD
608
DELISTED
Beard Energy Transition Acquisition Corp.
BRD
| $12.4M | 0.03% |
1,250,000
| – | – |
|
609
Axcelis
ACLS
$4.29B
| $12.3M | 0.03% |
+225,000
| New | +$13M |
|
|
SDAC
610
DELISTED
Sustainable Development Acquisition I Corp. Class A Common Stock
SDAC
| $12.3M | 0.03% |
1,250,000
| – | – |
|
611
Velocity Financial
VEL
$700M
| $12.3M | 0.03% |
1,118,763
-15,691
| -1% | -$167K |
|
|
BLSA
612
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $12.3M | 0.03% |
1,237,500
| – | – |
|
|
IPVI
613
DELISTED
InterPrivate IV InfraTech Partners Inc. Class A Common Stock
IPVI
| $12.3M | 0.03% |
1,250,000
| – | – |
|
614
Alkami Technology
ALKT
$2.02B
| $12.2M | 0.03% |
879,826
+121,203
| +16% | +$1.53M |
|
615
Merit Medical Systems
MMSI
$5.12B
| $12.2M | 0.03% |
+225,000
| New | +$13.7M |
|
616
Gen Digital
GEN
$16.9B
| $12.2M | 0.03% |
556,016
-479,100
| -46% | -$11.8M |
|
617
Church & Dwight Co
CHD
$24.4B
| $12.2M | 0.03% |
131,574
-71,100
| -35% | -$6.72M |
|
|
INZY
618
DELISTED
Inozyme Pharma
INZY
| $12.1M | 0.03% |
2,546,672
+800,000
| +46% | +$3.48M |
|
|
GHLD
619
DELISTED
Guild Holdings
GHLD
| $12.1M | 0.03% |
1,186,796
+128,874
| +12% | +$1.24M |
|
620
Eastman Chemical
EMN
$8.45B
| $12.1M | 0.03% |
134,243
-500
| -0.4% | -$51.8K |
|
621
Las Vegas Sands
LVS
$29.8B
| $12M | 0.03% |
358,100
-900
| -0.3% | -$31.1K |
|
622
Aflac
AFL
$63.7B
| $12M | 0.03% |
217,174
-409,300
| -65% | -$24.2M |
|
|
ICNC
623
DELISTED
Iconic Sports Acquisition Corp.
ICNC
| $12M | 0.03% |
1,200,000
| – | – |
|
|
PR
624
Permian Resources
PR
$17.2B
| $12M | 0.03% |
+2,000,000
| New | +$16M |
|
625
GitLab
GTLB
$6.16B
| $12M | 0.03% |
225,000
-225,000
| -50% | -$10.5M |
|
Similar funds
Adage Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.
- Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
- Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
- Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
- Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
- Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
- Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
- Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.
Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.